Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 12/20 | 0.84 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.84 |
| ▸ | MAPT | P10636 | 2/20 | 0.84 |
| ▸ | POLB | P06746 | 1/20 | 0.84 |
| ▸ | GAA | P10253 | 1/20 | 0.84 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.80 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.80 |
| ▸ | TSHR | P16473 | 1/20 | 0.80 |
| ▸ | PGR | P06401 | 3/20 | 0.77 |
| ▸ | LMNA | P02545 | 3/20 | 0.77 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.77 |
| ▸ | AR | P10275 | 2/20 | 0.77 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.75 |
| ▸ | NR3C1 | P04150 | 4/20 | 0.70 |
| ▸ | NR3C2 | P08235 | 3/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.70 |
| ▸ | SHBG | P04278 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13669677 | 1.00 | HIF1A (0.84) | HIF1ASMN1; SMN2MAPTPOLBGAA | |
| SCHEMBL2679288 | 0.94 | HIF1A (0.95) | HIF1ASMN1; SMN2MAPTPOLBGAA | |
| SCHEMBL4450347 | 0.94 | HIF1A (0.86) | HIF1ASMN1; SMN2MAPTPOLBGAA | |
| SCHEMBL13669679 | 0.94 | HIF1A (0.86) | HIF1ASMN1; SMN2MAPTPOLBGAA | |
| SCHEMBL80604 | 0.94 | HIF1A (0.95) | HIF1ASMN1; SMN2MAPTPOLBGAA | |
| SCHEMBL16018308 | 0.93 | HIF1A (0.93) | HIF1ASMN1; SMN2MAPTPOLBGAA | |
| SCHEMBL31249873 | 0.92 | HIF1A (0.84) | HIF1ASMN1; SMN2MAPTPOLBGAA | |
| SCHEMBL5084679 | 0.92 | HIF1A (0.98) | HIF1ASMN1; SMN2MAPTPOLBGAA | |
| SCHEMBL12089393 | 0.92 | HIF1A (0.82) | HIF1ASMN1; SMN2MAPTPOLBGAA | |
| SCHEMBL7137200 | 0.91 | HIF1A (1.00) | HIF1ASMN1; SMN2MAPTPOLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7605151-B2 | angiogenesis inhibitor; antiinflammatory agents; immunosuppressants; steroids conjugated compound | NICOX S.A. (FR) | 2009-10-20 | — | — | US | disclosed |
| US-20080234242-A1 | NITRATE ESTERS OF CORTICOID COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF | NICOX S.A. (FR) | 2008-09-25 | — | — | US | disclosed |
| US-7368442-B2 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | NICOX S.A. (FR) | 2008-05-06 | — | — | US | disclosed |
| US-20070161612-A1 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | NICOX S.A. | 2007-07-12 | — | — | US | disclosed |
| US-7205288-B2 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | NICOX S.A. (FR) | 2007-04-17 | — | — | US | disclosed |
| US-7196075-B2 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | NICOX S.A. (FR) | 2007-03-27 | — | — | US | disclosed |
| US-7160871-B2 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | NICOX S.A. (FR) | 2007-01-09 | — | — | US | disclosed |
| US-7157450-B2 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | NICOX S.A. (FR) | 2007-01-02 | — | — | US | disclosed |
| US-20060270644-A1 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | NICOX S.A. | 2006-11-30 | — | — | US | disclosed |
| US-20060160781-A1 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | NICOX S.A. (FR) | 2006-07-20 | — | — | US | disclosed |
| US-20060160780-A1 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | NICOX S.A. (FR) | 2006-07-20 | — | — | US | disclosed |
| US-20060154905-A1 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | NICOX S.A. (FR) | 2006-07-13 | — | — | US | disclosed |
| US-7056905-B2 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | NICOX S.A. (FR) | 2006-06-06 | — | — | US | disclosed |
| US-20050004089-A1 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | NICOX S.A. | 2005-01-06 | — | — | US | disclosed |
| US-6610676-B1 | Treating arthritis | NICOX S.A. (FR) | 2003-08-26 | — | — | US | disclosed |
| EP-0929565-B1 | NITRATE ESTERS OF CORTICOID COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF | NICOX SA (FR) | 2002-05-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070161612-A1 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | NR3C2, CYP11B2, NR3C1 | HIF1A 2540/4885SMN1; SMN2 4089/4885MAPT 3509/4885 |
| US-20080234242-A1 | NITRATE ESTERS OF CORTICOID COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF | NR3C2, CYP11B2, NR3C1 | HIF1A 2540/4885SMN1; SMN2 4089/4885MAPT 3509/4885 |
| US-20060154905-A1 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | NR3C2, CYP11B2, NR3C1 | HIF1A 2540/4885SMN1; SMN2 4089/4885MAPT 3509/4885 |
| US-20050004089-A1 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | NR3C2, CYP11B2, NR3C1 | HIF1A 2540/4885SMN1; SMN2 4089/4885MAPT 3509/4885 |
| US-20060270644-A1 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | NR3C2, CYP11B2, NR3C1 | HIF1A 2540/4885SMN1; SMN2 4089/4885MAPT 3509/4885 |
| US-20060160780-A1 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | NR3C2, CYP11B2, NR3C1 | HIF1A 2540/4885SMN1; SMN2 4089/4885MAPT 3509/4885 |
| US-20060160781-A1 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | NR3C2, CYP11B2, NR3C1 | HIF1A 2540/4885SMN1; SMN2 4089/4885MAPT 3509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.